Baoji Pharmaceutical received over US$100 million in Series B financing
Baoji Pharmaceutical is a biopharmaceutical R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. The company can produce recombinant protein drugs and recombinant antibody drugs on a large scale, focusing on providing innovative and disruptive solutions for clinical needs. Recently, Baoji Pharmaceuticals completed a Series B financing of over US$100 million. The […]
Baoji Pharmaceutical received over US$100 million in Series B financing Read More »